Mark E. Boulding
2016
In 2016, Mark E. Boulding earned a total compensation of $1.9M as Executive Vice President, Chief Legal Officer and Corporate Secretary at PTC Therapeutics, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,302 |
|---|---|
| Option Awards | $1,341,963 |
| Salary | $421,476 |
| Other | $14,455 |
| Total | $1,921,196 |
Boulding received $1.3M in option awards, accounting for 70% of the total pay in 2016.
Boulding also received $143.3K in non-equity incentive plan, $421.5K in salary and $14.5K in other compensation.
Rankings
In 2016, Mark E. Boulding's compensation ranked 5,065th out of 14,075 executives tracked by ExecPay. In other words, Boulding earned more than 64.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,065 out of 14,075 | 64th |
Division Manufacturing | 1,807 out of 5,489 | 67th |
Major group Chemicals And Allied Products | 573 out of 1,895 | 70th |
Industry group Drugs | 429 out of 1,538 | 72nd |
Industry Pharmaceutical Preparations | 344 out of 1,176 | 71st |
Source: SEC filing on April 27, 2017.
Boulding's colleagues
We found four more compensation records of executives who worked with Mark E. Boulding at PTC Therapeutics in 2016.